After a pair of key milestones this year, a startup working on a new way to treat cancer is opening an office in Baltimore city.
ImmuCision BioTherapeutics is taking office and lab space in the space at the University of Maryland BioPark at 801 Baltimore St.
{iframe}https://technical.ly/baltimore/2018/09/06/immunotherapy-startup-moves-into-the-university-of-maryland-biopark/?utm_content=buffer92cca&utm_medium=social&utm_source=twitter.com&utm_campaign=buffer{/iframe}